Basic information Safety Supplier Related

27-DEOXYACTEIN

Basic information Safety Supplier Related

27-DEOXYACTEIN Basic information

Product Name:
27-DEOXYACTEIN
Synonyms:
  • 23-EPI-26-Deoxyactein (20 mg)
  • DEOXYACTEIN, 27-(23-EPI-26-DEOXYACTEIN)(P)
  • (3beta,12beta,16beta,23S,24R,25R)-12-(Acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl beta-D-xylopyranoside
  • DEOXYACTEIN, 27-
  • 23-EPI-26-DEOXYACTEIN
  • 26-DEOXYACTEIN
  • 27-DEOXYACTEIN
  • β-D-Xylopyranoside, (3β,12β,16β,23S,24R,25R)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl
CAS:
264624-38-6
MF:
C37H56O10
MW:
660.83
Mol File:
264624-38-6.mol
More
Less

27-DEOXYACTEIN Chemical Properties

Melting point:
253~254℃
Density 
1.32±0.1 g/cm3(Predicted)
storage temp. 
Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility 
Chloroform (Slightly), Methanol (Very Slightly), Pyridine (Slightly)
form 
Solid
pka
13.03±0.70(Predicted)
color 
White to Off-White
Stability:
Hygroscopic
Major Application
pharmaceutical (small molecule)
InChIKey
GCMGJWLOGKSUGX-RBKCHLQLSA-N
More
Less

Safety Information

WGK Germany 
WGK 3
Storage Class
11 - Combustible Solids
More
Less

27-DEOXYACTEIN Usage And Synthesis

Description

23-epi-26-Deoxyactein is a triterpene glycoside and a major constituent of black cohosh (C. racemosa). It reduces intracellular calcium concentrations, collapse of the mitochondrial membrane potential, production of reactive oxygen species (ROS), and cardiolipin peroxidation and inhibits autophagy and apoptosis in osteoblastic MC3T3-E1 cells induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). 23-epi-26-Deoxyactein (0.01-10 μM) reduces production of ROS and IL-1β and cell death induced by methylglyoxal in RIN-m5F β-cells.

Uses

27-Deoxyactein has shown stimulation of osteoblast function and inhibits bone resorbing mediators in the treatment of osteoporosis. It is a derivative of Actein (A191800), a gamma secretase modulators derived from botanicals.

Definition

ChEBI: 26-Deoxyactein is a triterpenoid. It has a role as a metabolite.

Synthesis

Compounds (20R, 24R)-24,25-16,23-23,27-trioxo-12-acetoxy-9. 19-cyclolanostane-3-O-??-D-xylopyranoside was prepared by taking the dried rhizome of Asclepiadaceae Cimicifuga foetida L., pulverized After extracted with 80% methanol aqueous solution at 90 ?? reflux 3 times, the extract to remove most of the methanol, respectively, with petroleum ether, chloroform, n-butanol extraction; recovery of solvents, petroleum ether part, chloroform part, n-butanol part; chloroform part of the mixing of silica gel samples, silica gel chromatography; chloroform: methanol gradient eluted with 1: 0, 40:1, 20: 1, 10: 1, the same portion of the TLC combined to obtain four fractions of Fr. A-D; Fr.B was separated by chromatography at atmospheric pressure on a silica gel column with a 40:1 chloroform:methanol gradient elution, and the compounds (20R, 24R)-24, 25-16, 23-, 23-27-trioxirane were obtained by repeated elution with 40:1 chloroform:methanol. 23,27-trioxo-12-acetoxy-9,19-cyclolanostane-3-O- ?? -D-Xylopyranoside. C37H56O10, colorless needle crystal, mp 253-254??C, [??]D = -61.2?? (c = 0.255, CHCl3-CH3OH (1:1)).

References

[1] KWANG SIK SUH. 27-Deoxyactein prevents 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cellular damage in MC3T3-E1 osteoblastic cells.[J]. Journal of Environmental Science and Health Part A-toxic\/hazardous Substances & Environmental Engineering, 2018, 53 6: 561-570. DOI: 10.1080/10934529.2018.1428275
[2] KWANG SIK SUH. Deoxyactein protects pancreatic β-cells against methylglyoxal-induced oxidative cell damage by the upregulation of mitochondrial biogenesis.[J]. International journal of molecular medicine, 2017, 40 2: 539-548. DOI: 10.3892/ijmm.2017.3018

27-DEOXYACTEINSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Email
sj_scrc@sinopharm.com
Chengdu Biopurify Phytochemicals Ltd.
Tel
+86-028-82633397 18982077548
Email
cwb1@biopurify.cn
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Shanghai Tauto Biotech Co., Ltd.
Tel
021-51320588
Email
tauto@tautobiotech.com